Results 191 to 200 of about 97,027 (246)

Nanoformulated <i>Walterinnesia aegyptia</i> Venom Enhances Therapeutic Outcomes in Experimental Cutaneous Leishmaniasis: A Comparative Study of Hyaluronic Acid and Silver Nanoparticles. [PDF]

Nanomaterials (Basel)
Al-Aqil A, Al Nasr IS, Hakami H, Abou El Fadl F, Wang C, Al-Shammari M, Alotaibi S, Alotaibi S, Al-Qurashi A, Al-Rashid H, Al-Olayan E.   +10 more
europepmc   +1 more source

Revisiting visceral leishmaniasis in immunocompromised patients: Ongoing gaps and advances in diagnostics, therapies, and preventive measures. [PDF]

Curr Res Parasitol Vector Borne Dis
Partovi Moghaddam S, Sharifi I, Lotfalizadeh N, Amini S, Mobaraki A, Fazel B, Bamorovat M, Khosravi A, Akhtardanesh B, Mohebali M.   +9 more
europepmc   +1 more source

Mysterious Leishmania martiniquensis parasites and their relatives of the subgenus Mundinia: Emerging pathogens reshaping our understanding of leishmaniases. [PDF]

PLoS Pathog
Volf P, Sadlova J.
europepmc   +1 more source

First imported case of New World leishmaniasis in Romania: diagnostic and therapeutic challenges in a non-endemic country. [PDF]

Infect Dis Poverty
Mihalca AD, Mitrea IB, Lupșe MS, Ionică AM, Baneth G, Nachum-Biala Y, Kumar J, Taulescu M, Dantas-Torres F, de Macedo FMR, Șenilă SC.   +10 more
europepmc   +1 more source

Trypanosomatids in Costa Rican Bats: First Molecular Evidence of the Leishmania (Viannia) guyanensis Complex and Evidence of a Broader Host Association for Trypanosoma minasense. [PDF]

Acta Parasitol
Rubí-Chacón R, Urbina-Villalobos A, Sibaja-Morales KD, Zuniga-Moya MJ, Dolz G.   +4 more
europepmc   +1 more source

Revisiting Leishmania (Viannia) lainsoni Silveira, Shaw, Braga, and Ishikawa, 1987: current knowledge and emerging perspectives. [PDF]

Parasit Vectors
de Morais TG, Campos MB, Silveira FT, Vasconcelos Dos Santos T.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antileishmanial Activity of Azitahromycin Against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi

The American Journal of Tropical Medicine and Hygiene, 2008
Azithromycin, an azalide antibiotic, is highly concentrated within different phagocytic cells, especially macrophages. The potential antileishmanial activity of azithromycin against three species of Leishmania from the New World was assessed using in vitro models.
Fernanda, de Oliveira-Silva, Eliane, de Morais-Teixeira, Ana, Rabello   +2 more
openaire   +2 more sources

Detection of Leishmania (Leishmania) amazonensis and Leishmania (Leishmania) infantum chagasi in Brazilian bats

Veterinary Parasitology, 2010
Although bats are one of the most abundant mammals in the new world and are present in virtually all ecosystems, including urban and peri-urban environments, few studies have investigated the role of these animals in the epidemiological chain of leishmaniosis.
Elisa San Martin Mouriz, Savani, Marilene Fernandes, de Almeida, Maria Cecília Gibrail, de Oliveira Camargo, Sandra Regina Nicoletti, D'Auria, Miriam Martos Sodré, Silva, Maria Lúcia, de Oliveira, Débora, Sacramento   +6 more
openaire   +2 more sources

In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis

Experimental Parasitology, 2022
Tegumentary leishmaniasis is an endemic disease that urgently needs new and effective treatments. L. amazonensis is one of the main species involved in the transmission of this infectious and non-contagious disease. The currently available treatments for leishmaniasis have high toxicity and vary in efficacy.
Aline Ávila Brustolin, Áquila Carolina Fernandes Herculano Ramos-Milaré, Tatiane França Perles de Mello, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Thaís Gomes Verzignassi Silveira   +5 more
openaire   +2 more sources